Insmed
INSM
#542
Rank
HK$338.56 B
Marketcap
HK$1,587
Share price
-0.51%
Change (1 day)
170.81%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -HK$8.59 Billion

According to Insmed's latest financial reports the company's current earnings are HK$0.44 Billion. In 2024 the company made an earning of -HK$6.46 Billion a decrease over its 2023 earnings that were of -HK$5.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$8.59 Billion32.92%
2024 -HK$6.46 Billion23.71%
2023 -HK$5.22 Billion45.77%
2022 -HK$3.59 Billion15.83%
2021 -HK$3.1 Billion50.19%
2020 -HK$2.06 Billion16.4%
2019 -HK$1.77 Billion-23.9%
2018 -HK$2.33 Billion59.35%
2017 -HK$1.46 Billion8.52%
2016 -HK$1.35 Billion47.25%
2015 -HK$0.92 Billion34.53%
2014 -HK$0.68 Billion58.83%
2013 -HK$0.43 Billion35.14%
2012 -HK$0.32 Billion-31.92%
2011 -HK$0.47 Billion854.92%
2010 -HK$48.62 Million-105.22%
2009 HK$0.93 B-905.06%
2008 -HK$0.12 Billion-27.31%
2007 -HK$0.16 Billion-62.41%
2006 -HK$0.43 Billion98.19%
2005 -HK$0.22 Billion0.03%
2004 -HK$0.22 Billion159.07%
2003 -HK$82.38 Million-69.31%
2002 -HK$0.27 Billion
2000 -HK$0.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-HK$1.97 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.76 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
HK$76.93 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
HK$34.31 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$34.71 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA